Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Goldenberg

Showing results (121-130 of 296) with videos related to

Pageof 30
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 23, 2011
Optimization of hapten-peptide labeling for pretargeted immunoPET of bispecific antibody using generator-produced 68GaHabibe Karacay, Robert M Sharkey, William J McBride, et al.
Blood|June 18, 2011
Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancersEdmund A Rossi, Diane L Rossi, Thomas M Cardillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitisDavid V Gold, David E Modrak, Zhiliang Ying, et al.
Blood|August 20, 2005
Effective therapy of human lymphoma xenografts with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody immunotoxinChien-Hsing Chang, Puja Sapra, Sailaja S Vanama, et al.
Molecular Cancer Therapeutics|February 22, 2013
Milatuzumab-SN-38 conjugates for the treatment of CD74+ cancersSerengulam V Govindan, Thomas M Cardillo, Robert M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an updateRobert M Sharkey, Habibe Karacay, William J McBride, et al.
Blood|July 4, 2013
Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumabEdmund A Rossi, David M Goldenberg, Rosana Michel, et al.
Nuclear Medicine and Biology|September 23, 2003
Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74Rosana B Michel, Adriane V Rosario, Martin W Brechbiel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2006
Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targetingEdmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.
Journal of Medicinal Chemistry|October 23, 2008
Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapySung-Ju Moon, Serengulam V Govindan, Thomas M Cardillo, et al.
Pageof 30

Showing results (121-130 of 296) with videos related to

Sort By:
Pageof 30
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 23, 2011
Optimization of hapten-peptide labeling for pretargeted immunoPET of bispecific antibody using generator-produced 68GaHabibe Karacay, Robert M Sharkey, William J McBride, et al.
Blood|June 18, 2011
Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancersEdmund A Rossi, Diane L Rossi, Thomas M Cardillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitisDavid V Gold, David E Modrak, Zhiliang Ying, et al.
Blood|August 20, 2005
Effective therapy of human lymphoma xenografts with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody immunotoxinChien-Hsing Chang, Puja Sapra, Sailaja S Vanama, et al.
Molecular Cancer Therapeutics|February 22, 2013
Milatuzumab-SN-38 conjugates for the treatment of CD74+ cancersSerengulam V Govindan, Thomas M Cardillo, Robert M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an updateRobert M Sharkey, Habibe Karacay, William J McBride, et al.
Blood|July 4, 2013
Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumabEdmund A Rossi, David M Goldenberg, Rosana Michel, et al.
Nuclear Medicine and Biology|September 23, 2003
Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74Rosana B Michel, Adriane V Rosario, Martin W Brechbiel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2006
Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targetingEdmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.
Journal of Medicinal Chemistry|October 23, 2008
Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapySung-Ju Moon, Serengulam V Govindan, Thomas M Cardillo, et al.
Pageof 30